167 related articles for article (PubMed ID: 22528093)
1. Search for amyloid-binding proteins by affinity chromatography.
Calero M; Rostagno A; Ghiso J
Methods Mol Biol; 2012; 849():213-23. PubMed ID: 22528093
[TBL] [Abstract][Full Text] [Related]
2. Interaction between human amphipathic apolipoproteins and amyloid beta-peptide: surface plasmon resonance studies.
Shuvaev VV; Siest G
FEBS Lett; 1996 Mar; 383(1-2):9-12. PubMed ID: 8612800
[TBL] [Abstract][Full Text] [Related]
3. Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation.
Oyama R; Yamamoto H; Titani K
Biochim Biophys Acta; 2000 Jun; 1479(1-2):91-102. PubMed ID: 11004532
[TBL] [Abstract][Full Text] [Related]
4. Mapping the interactions between the Alzheimer's Aβ-peptide and human serum albumin beyond domain resolution.
Algamal M; Milojevic J; Jafari N; Zhang W; Melacini G
Biophys J; 2013 Oct; 105(7):1700-9. PubMed ID: 24094411
[TBL] [Abstract][Full Text] [Related]
5. In Search for Low-Molecular-Weight Ligands of Human Serum Albumin That Affect Its Affinity for Monomeric Amyloid β Peptide.
Deryusheva EI; Shevelyova MP; Rastrygina VA; Nemashkalova EL; Vologzhannikova AA; Machulin AV; Nazipova AA; Permyakova ME; Permyakov SE; Litus EA
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732194
[TBL] [Abstract][Full Text] [Related]
6. Identification of Clusterin as a Major ABri- and ADan-Binding Protein Using Affinity Chromatography.
Rostagno A; Calero M; Ghiso J
Methods Mol Biol; 2022; 2466():49-60. PubMed ID: 35585310
[TBL] [Abstract][Full Text] [Related]
7. The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation.
Golabek AA; Soto C; Vogel T; Wisniewski T
J Biol Chem; 1996 May; 271(18):10602-6. PubMed ID: 8631862
[TBL] [Abstract][Full Text] [Related]
8. Arrest of beta-amyloid fibril formation by a pentapeptide ligand.
Tjernberg LO; Näslund J; Lindqvist F; Johansson J; Karlström AR; Thyberg J; Terenius L; Nordstedt C
J Biol Chem; 1996 Apr; 271(15):8545-8. PubMed ID: 8621479
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein J and Alzheimer's amyloid beta solubility.
Matsubara E; Soto C; Governale S; Frangione B; Ghiso J
Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):671-9. PubMed ID: 8687416
[TBL] [Abstract][Full Text] [Related]
10. High-affinity multivalent interactions between apolipoprotein E and the oligomers of amyloid-β.
Ghosh S; Sil TB; Dolai S; Garai K
FEBS J; 2019 Dec; 286(23):4737-4753. PubMed ID: 31287614
[TBL] [Abstract][Full Text] [Related]
11. N-terminal domain of myelin basic protein inhibits amyloid beta-protein fibril assembly.
Liao MC; Hoos MD; Aucoin D; Ahmed M; Davis J; Smith SO; Van Nostrand WE
J Biol Chem; 2010 Nov; 285(46):35590-8. PubMed ID: 20807757
[TBL] [Abstract][Full Text] [Related]
12. Ca(2+)-dependent binding of human serum amyloid P component to Alzheimer's beta-amyloid peptide.
Hamazaki H
J Biol Chem; 1995 May; 270(18):10392-4. PubMed ID: 7737971
[TBL] [Abstract][Full Text] [Related]
13. Chemical modifications of amyloid-β(1-42) have a significant impact on the repertoire of brain amyloid-β(1-42) binding proteins.
Medvedev AE; Buneeva OA; Kopylov AT; Mitkevich VA; Kozin SA; Zgoda VG; Makarov AA
Biochimie; 2016; 128-129():55-8. PubMed ID: 27400251
[TBL] [Abstract][Full Text] [Related]
14. Anti-amyloidogenic property of human gastrokine 1.
Altieri F; Di Stadio CS; Severino V; Sandomenico A; Minopoli G; Miselli G; Di Maro A; Ruvo M; Chambery A; Quagliariello V; Masullo M; Rippa E; Arcari P
Biochimie; 2014 Nov; 106():91-100. PubMed ID: 25139219
[TBL] [Abstract][Full Text] [Related]
15. The binding of monomeric amyloid β peptide to serum albumin is affected by major plasma unsaturated fatty acids.
Litus EA; Kazakov AS; Sokolov AS; Nemashkalova EL; Galushko EI; Dzhus UF; Marchenkov VV; Galzitskaya OV; Permyakov EA; Permyakov SE
Biochem Biophys Res Commun; 2019 Mar; 510(2):248-253. PubMed ID: 30685090
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Alzheimer beta-peptide fibril formation by serum amyloid P component.
Janciauskiene S; García de Frutos P; Carlemalm E; Dahlbäck B; Eriksson S
J Biol Chem; 1995 Nov; 270(44):26041-4. PubMed ID: 7592799
[TBL] [Abstract][Full Text] [Related]
17. In vitro amyloid-β binding and inhibition of amyloid-β self-association by therapeutic albumin.
Milojevic J; Costa M; Ortiz AM; Jorquera JI; Melacini G
J Alzheimers Dis; 2014; 38(4):753-65. PubMed ID: 24072068
[TBL] [Abstract][Full Text] [Related]
18. A solution NMR toolset to probe the molecular mechanisms of amyloid inhibitors.
Ahmed R; Melacini G
Chem Commun (Camb); 2018 May; 54(37):4644-4652. PubMed ID: 29658548
[TBL] [Abstract][Full Text] [Related]
19. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.
Montoliu-Gaya L; Mulder SD; Veerhuis R; Villegas S
PLoS One; 2017; 12(11):e0188191. PubMed ID: 29155887
[TBL] [Abstract][Full Text] [Related]
20. Spectrofluorimetric analysis of the interaction of amyloid peptides with neuronal nitric oxide synthase: implications in Alzheimer's disease.
Padayachee ER; Whiteley CG
Biochim Biophys Acta; 2011 Dec; 1810(12):1136-40. PubMed ID: 21930189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
